VEGFA and cancer: Regarding methotrexate, VEGF inhibition is a known mechanism of cardiotoxicity [10], but it has also been suggested to mediate methotrexate’s pharmacodynamic action [77], coherently with the notion that angiogenesis is a fundamental aspect of cancer biology.